0

PET and Planar Imaging of Tumor Hypoxia With Labeled Metronidazole

Megumi Ito, David J Yang, Osama Mawlawi, Richard Mendez, Chang-Sok Oh, Ali Azhdarinia, Allison C Greenwell, Dong-Fang Yu, E Edmund Kim

Acad Radiol. 2006 May;13(5):598-609.

PMID: 16627201

Abstract:

Rationale and objectives:
This study was aimed to develop 99mTc- and 68Ga-labeled metronidazole (MN) using ethylenedicysteine (EC) as a chelator and evaluate their potential use to assess tumor hypoxia.
Materials and methods:
EC-MN was labeled with 99mTc in the presence of tin (II) chloride. Labeling EC-MN with 68Ga was achieved by adding 68GaCl3 (2 mCi with 3.4 microg cold GaCl3). In vitro cellular uptakes of 99mTc- and 68Ga-EC-MN were obtained in various types of tumor cells at 0.5-4 hours. Tissue distribution and PET imaging of 99mTc and 68Ga-EC-MN were evaluated in breast tumor-bearing rats at 0.5-4 hours. Tumor oxygen tension was measured using an oxygen probe.
Results:
There were similar cellular uptakes (2-10%) between 99mTc- and 68Ga-EC-MN at 0.5-4 hours. In vivo biodistribution of 99mTc- and 68Ga-EC-MN in breast tumor-bearing rats showed increased tumor-to-blood and tumor-to-muscle count density ratios as a function of time. Positron emission tomography images confirmed that the tumors could be visualized clearly with 68Ga-EC-MN. Oxygen tension in tumor tissue was determined to be 6-10 mm Hg compared with 40-50 mm Hg in normal muscle tissue.
Conclusions:
The results indicated that it is feasible to use 99mTc- and 68Ga-EC-MN for assessment of tumor hypoxia. These agents may be useful in selecting and evaluating cancer therapy.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP24597124 Gallium(II) chloride Gallium(II) chloride 24597-12-4 Price
qrcode